Client: Greenwich Biosciences
Role: Creative Director
Helped launch and grow the world’s first FDA-approved CBD drug available for rare epilepsies. While producing a new category of pharmacuetical drug, and navigating uncharted and changing legal landscape, we focused on developing a best in class user experience and telling the story of caregivers and patients – and the massive benefit that CBD has brought to their lives.
Exploring their transformed lives helped us develop meaningful communications and gain rich insights to establish our brand for them.
Building the visual look of the brand, that took taking into account the triggers of epilepsies was just the floor. We developed lots of video, launched our social channels on Youtube and Facebook and celebrated the success of bringing this treatment to over 35,000 patients.
EPIDIOLEX WEBSITE
